The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 37 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Gonadotropin-Releasing Hormone  [Clear All Filters]
2019
Stamou, M. I., Plummer L., Galli-Tsinopoulou A., Stergidou D., Koika V., & Georgopoulos N. A. (2019).  Unilateral renal agenesis as an early marker for genetic screening in Kallmann syndrome.. Hormones (Athens). 18(1), 103-105.
2018
Lainas, G. T., Lainas T. G., Venetis C. A., Sfontouris I. A., Zorzovilis I. Z., Alexopoulou E., et al. (2018).  Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.. Ultrasound Obstet Gynecol. 51(1), 126-133.
2016
Venetis, C. A., Kolibianakis E. M., Bosdou J. K., Lainas G. T., Sfontouris I. A., Tarlatzis B. C., et al. (2016).  Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.. Hum Reprod. 31(8), 1859-65.
Bosdou, J. K., Venetis C. A., Dafopoulos K., Zepiridis L., Chatzimeletiou K., Anifandis G., et al. (2016).  Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.. Hum Reprod. 31(5), 977-85.
2015
Lainas, T. G., & Kolibianakis E. M. (2015).  Authors' reply.. BJOG. 122(4), 585-6.
Dagklis, T., Kouvelas D., Kallaras K., Papazisis G., Petousis S., Margioula-Siarkou C., et al. (2015).  Leptin increases luteinizing hormone secretion of fasting female rats.. Clin Exp Obstet Gynecol. 42(1), 18-21.
Griesinger, G., Venetis C. A., Tarlatzis B., & Kolibianakis E. Michaelis (2015).  To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!. Reprod Biomed Online. 31(1), 6-8.
2014
Ganidou, M. A., Kolibianakis E. M., Venetis C. A., Gerou S., Makedos G. A., Klearchou N., et al. (2014).  Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study.. Gynecol Endocrinol. 30(11), 817-21.
Tsakos, E., Tolikas A., Daniilidis A., & Asimakopoulos B. (2014).  Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.. Arch Gynecol Obstet. 290(6), 1249-53.
Griesinger, G., Mannaerts B., Andersen C. Yding, Witjes H., Kolibianakis E. M., & Gordon K. (2014).  Reply of the authors.. Fertil Steril. 101(1), e5-6.
Lainas, G. T., Kolibianakis E. M., Sfontouris I. A., Zorzovilis I. Z., Petsas G. K., Lainas T. G., et al. (2014).  Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome.. BJOG. 121(7), 848-55.
2013
Fatemi, H. M., Polyzos N. P., van Vaerenbergh I., Bourgain C., Blockeel C., Alsbjerg B., et al. (2013).  Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.. Fertil Steril. 100(3), 742-7.
Prapas, Y., Petousis S., Dagklis T., Panagiotidis Y., Papatheodorou A., Assunta I., et al. (2013).  GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.. Eur J Obstet Gynecol Reprod Biol. 166(1), 43-6.
Humaidan, P., Polyzos N. P., Alsbjerg B., Erb K., Mikkelsen A. L., Elbaek H. O., et al. (2013).  GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.. Hum Reprod. 28(9), 2511-21.
Levy, M. J., Ledger W., Kolibianakis E. M., Ijzerman-Boon P. C., & Gordon K. (2013).  Is it possible to reduce the incidence of weekend oocyte retrievals in GnRH antagonist protocols?. Reprod Biomed Online. 26(1), 50-8.
Lainas, G. T., Kolibianakis E. M., Sfontouris I. A., Zorzovilis I. Z., Petsas G. K., Lainas T. G., et al. (2013).  Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.. Hum Reprod. 28(7), 1929-42.
Venetis, C. A., Kolibianakis E. M., Bosdou J. K., & Tarlatzis B. C. (2013).  Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles.. Hum Reprod Update. 19(5), 433-57.
Griesinger, G., Mannaerts B., Andersen C. Yding, Witjes H., Kolibianakis E. M., & Gordon K. (2013).  Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.. Fertil Steril. 100(6), 1622-8.e1-3.
2012
Kolibianakis, E. M., Griesinger G., & Venetis C. A. (2012).  GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data.. Hum Reprod Update. 18(2), 228-9; author reply 229-30.
Papanikolaou, E. G., Pados G., Grimbizis G., Bili E., Kyriazi L., Polyzos N. P., et al. (2012).  GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.. Hum Reprod. 27(6), 1822-8.
Lainas, G. T., Kolibianakis E. M., Sfontouris I. A., Zorzovilis I. Z., Petsas G. K., Tarlatzi T. B., et al. (2012).  Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study.. Reprod Biol Endocrinol. 10, 69.
Kolibianakis, E. M., Venetis C. A., Bontis J., & Tarlatzis B. C. (2012).  Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis.. Curr Pharm Biotechnol. 13(3), 464-70.
2011
Kyrou, D., Fatemi H. M., Zepiridis L., Riva A., Papanikolaou E. G., Tarlatzis B. C., et al. (2011).  Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial.. Hum Reprod. 26(5), 1020-4.
Kyrou, D., Kolibianakis E. M., Fatemi H. M., Tarlatzis B. C., Tournaye H., & Devroey P. (2011).  Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomize. Fertil Steril. 96(5), 1112-5.
Kolibianakis, E. M., Venetis C. A., Kalogeropoulou L., Papanikolaou E., & Tarlatzis B. C. (2011).  Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial.. Fertil Steril. 95(2), 558-62.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.